Keel Point, LLC Amgen Inc Transaction History

Keel Point, LLC

$1.19 Billion
Q3 2024

A detailed history of Keel Point, LLC transactions in Amgen Inc stock. As of the latest transaction made, Keel Point, LLC holds 2,655 shares of AMGN stock, worth $781,977. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,655

Previous 2,720 2.39%

Holding current value

$781,977

Previous $849,000 0.71%

% of portfolio

0.07%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $20,109 - $21,929	-65 Reduced 2.39%	2,655 $855,000
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $146,089 - $177,536	556 Added 25.69%	2,720 $849,000
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $11,023 - $13,306	41 Added 1.93%	2,164 $615,000
Q4 2023 Jan 30, 2024	BUY	$255.7 - $288.46 $27,359 - $30,865	107 Added 5.31%	2,123 $611,000
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $29,299 - $36,375	134 Added 7.12%	2,016 $541,000
Q2 2023 Jul 12, 2023	BUY	$214.27 - $253.37 $53,138 - $62,835	248 Added 15.18%	1,882 $417,000
Q1 2023 Apr 03, 2023	SELL	$225.79 - $275.2 $9,708 - $11,833	-43 Reduced 2.56%	1,634 $395,000
Q4 2022 Jan 17, 2023	BUY	$229.03 - $291.01 $46,493 - $59,075	203 Added 13.77%	1,677 $0
Q3 2022 Oct 05, 2022	BUY	$224.46 - $253.15 $4,938 - $5,569	22 Added 1.52%	1,474 $332,000
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $15,688 - $17,458	68 Added 4.91%	1,452 $366,000
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $22,584 - $24,984	103 Added 8.04%	1,384 $335,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $6,960 - $7,966	35 Added 2.81%	1,281 $288,000
Q3 2021 Nov 04, 2021	BUY	$212.27 - $248.7 $264,276 - $309,631	1,245 Added 124500.0%	1,246 $265,000
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $287,303 - $318,742	-1,230 Reduced 99.92%	1 $552,000
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $1,401 - $1,554	-6 Reduced 0.49%	1,231 $300,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $274,502 - $319,888	1,237 New	1,237 $308,000
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $679,166 - $765,569	-3,755 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $4,816 - $5,622	27 Added 0.72%	3,755 $731,000
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $8,152 - $9,191	44 Added 1.19%	3,728 $773,000
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $53,800 - $60,429	324 Added 9.64%	3,684 $680,000
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $16,943 - $19,800	100 Added 3.07%	3,360 $573,000
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $168 - $188	1 Added 0.03%	3,260 $567,000
Q3 2017 Nov 09, 2017	SELL	$167.29 - $191.0 $41,822 - $47,750	-250 Reduced 7.12%	3,259 $608,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,509	3,509 $604,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account